(DOSES, PK, ETC) QUESTIONS AND
ANSWERS WITH SOLUTIONS 2024
HowWmuchWelementalWcalciumWisWinWcalciumWcarbonate?W-WANSWERW40%
[1250WmgWCaCO3W=W500WmgWCa²+)
HowWmuchWelementalWcalciumWisWinWcalciumWcitrate?W-WANSWERW21%
[1500WmgWCa-citrateW=W315WmgWCa²+)
InWwhichWtypeWofWkineticsWdoesWtheWserumWconcentrationWrelateWproportionallyWtoWtheWamountWofWdru
g?W-WANSWERWFirstWorderWkinetics
InWwhichWtypeWofWkineticsWdoesWtheWserumWconcentrationWnotWrelateWproportionallyWtoWtheWamountWof
Wdrug?W-WANSWERWZeroWorder,WorWMichaelis-MentenWkinetics
WhichWtypeWofWkineticsWisWcharacterizedWbyWsaturationWofWoneWorWmoreWmechanismsWofWADME?W-
WANSWERWZeroWorder,WorWMichaelis-MentenWkinetics
WhatWrangeWofWserumWconcentrationWisWtherapeuticWforWCBZ?W-WANSWERW6-12Wμg/mL
WhatWrangeWofWserumWconcentrationWisWtherapeuticWforWlevothyroxine?W-
WANSWERWdosedWtoWnormalWfreeWT4WandWTSHWlevels
FT4W=W0.8-1.7Wμg/dL
TSHW=W0.3-3.0WμIU/mL
WhatWrangeWofWserumWconcentrationWisWtherapeuticWforWlithiumWinWmaintenanceWtherapy?WInWtreatmen
tWofWacuteWsymptoms?W-WANSWERWmaintenanceW0.6-1.2WmEq/L
acuteWsymptomsWupWtoW1.5WmEq/L
WhatWserumWconcentrationsWareWtherapeuticWforWphenytoin?W-WANSWERW10-20Wμg/mL
, WhatWserumWconcentrationsWareWtherapeuticWforWtheophylline?W-WANSWERW5-15Wμg/mL
WhatWserumWconcentrationsWareWtherapeuticWforWdigoxin?W-WANSWERW0.8-2.0Wng/mLWforWCHF
2.0-2.5W(?)Wng/mLWforWAfib
WhatWserumWconcentrationsWareWtherapeuticWforWvalproicWacid?W-WANSWERW50-100Wμg/mL
WhatWisWtheWnormalWdoseWofWfolateWinWOTCWproducts,WandWatWwhatWdoseWisWitWRxWonly?W-
WANSWERWOTCW0.4-0.8Wmg/day
RxW1Wmg/day
WhatWoneWtimeWdoseWofWazithromycinWisWusedWtoWtreatWchlamydia,Wgonorrhea,WorWboth?W-
WANSWERWchlamydiaW1Wg
gonorrheaWorWbothW2Wg
WhatWisWtheWappropriateWdurationWofWtreatmentWofWacuteWuncomplicatedWcystitisWinWaWfemaleWwithWSe
ptraWDS,WCipro,WLevaquin,WorWnitrofurantoin?W-
WANSWERW3WdaysW(SeptraWDSWbid,WCiproW250Wbid,WCiproWERW500Wqday,WLevaquinW250Wqday)
5WdaysW(nitrofurantoinW100WmgWbid)
WhatWisWtheWappropriateWmedicationWandWdurationWofWtreatmentWforWuncomplicatedWcystitisWinWpregna
ncy?W-WANSWERWβ-lactamWxW7Wdays
WhatWisWtheWappropriateWdurationWofWoutpatientWtreatmentWofWpyelonephritisWwithWFQsWwithWunknown
WorWlowWresistance?W-WANSWERW5-7Wdays
WhatWisWtheWappropriateWdurationWofWtreatmentWforWsevereWpyelonephritis?W-WANSWERW10-14Wdays
WhatWdoseWofWphenazopyridineWisWOTC,WwhichWisWRx?W-WANSWERWOTCW100WmgWTID
RxW200WmgWTID